Zymo Research’s DNA/RNA Shield™ Inactivates Monkeypox for the Collection and Transportation of Samples
IRVINE, Calif., July 15, 2022 /PRNewswire/ -- Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg, Germany, demonstrated data showing their DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolates. DNA/RNA Shield™ Inactivating Transport Medium (ITM) completely inactivated Monkeypox virus isolates. This data comes at a critical...
Nefertiti Greene Joins Mars Petcare to Run New Science & Diagnostics Division
Mars Petcare announces former Johnson & Johnson executive Nefertiti Greene as member of Global Petcare Leadership team Greene will head new division within Mars Petcare, Science & Diagnostics Demonstrates company's deep commitment to advancing science and innovation BRUSSELS, July 14, 2022 /PRNewswire/ -- Today, Mars Petcare, the leading pet health, services, and nutrition company, has named Nefertiti...
Lunit to be Listed on KOSDAQ next week
Initial Public Offering of 1,215,800 shares of its common stock at KRW 30,000 To be listed on the KOSDAQ market on July 21, 2022 SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- Lunit, a global provider of AI-based cancer solutions, announced that it priced its initial public offering (IPO) of 1,215,800...
Merck Launches its Uptune Program in Asia for Collaborating with Startups
Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologies and materials in semiconductor and smart manufacturing Selected startups can receive funding of up to € 100,000 SHANGHAI, July 14, 2022 /PRNewswire/ -- Merck, a leading science and technology company, today announced the...
Urgent support needed following the pandemic’s effect on cancer screening services
Dry July call to arms will improve support for cancer patients SYDNEY, July 14, 2022 /PRNewswire/ -- Dry July Foundation is urging Australians to dig even deeper this Dry July to help people affected by cancer. So many Australians could not access vital lifesaving cancer screenings and treatments because of the impact of COVID-19. Research conducted by Cancer Council revealed...
Tianlong launched a campaign to care for SMA children
XI'AN China, July 14, 2022 /PRNewswire/ -- Tianlong has launched a campaign together with the Spinal muscular atrophy (SMA) care center in China (a non-profit organization for SMA), and The Second Affiliated Hospital of Xi'an Jiaotong University to care for children with SMA in May 2022. Spinal muscular atrophy (SMA) is an inherited disease that affects nerves and muscles,...
Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals and Industry
SINGAPORE, July 14, 2022 /PRNewswire/ -- Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors. This funding will support Oncoshot's further expansion into Australia and India where, including its home country Singapore, it is...
Nanoform and Pharmanovia to breathe new life into iconic medicines
HELSINKI, July 14, 2022 /PRNewswire/ -- Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, today announced that it has partnered with Pharmanovia, a fast-growing specialty pharma business with a portfolio of over 20 branded drugs in 140 markets. The new strategic partnership aims to add value to branded prescription medicines. Pharmanovia will look to apply Nanoform's proprietary nanoparticle technologies and...
GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs
SEOUL, South Korea, July 14, 2022 /PRNewswire/ -- On the July 14, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and DAAN Bio Therapeutics (Byoung Chul Cho, Co-Founder & CEO), an innovative new drug developer such as antibody treatments and cell therapy drugs, announced that they had entered into a strategic cooperation...
Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs
NANJING, China, July 14, 2022 /PRNewswire/ -- On July 13, 2022, Triastek, Inc. ("Triastek") announced a collaboration with Eli Lilly and Company ("Lilly"), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and programmed release of drugs in specific regions of the GI...
